Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. David Spetzler, President and Chief Scientific Officer at Caris Life Sciences®, to discuss the latest advances in liquid biopsies, the clinical utility of these offerings, and how precision oncology is leveraging this new source of molecular information to improve patient outcomes.
For more information, please visit: www.CarisLifeSciences.com
